Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
0.7738
-0.0462 (-5.63%)
At close: Nov 13, 2026, 4:00 PM EST
0.7678
-0.0060 (-0.78%)
After-hours: Nov 13, 2026, 7:18 PM EST
Compass Therapeutics Employees
Compass Therapeutics had 39 employees as of December 31, 2025. The number of employees increased by 4 or 11.43% compared to the previous year. That makes Compass Therapeutics the 36,129th largest employer in the world and 4,921st in the United States.
Employees
39
Change (1Y)
4
Growth (1Y)
11.43%
Revenue / Employee
n/a
Profits / Employee
-$2,214,308
Market Cap
139.35M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 39 | 4 | 11.43% |
| Dec 31, 2024 | 35 | 3 | 9.38% |
| Dec 31, 2023 | 32 | 6 | 23.08% |
| Dec 31, 2022 | 26 | 2 | 8.33% |
| Dec 31, 2021 | 24 | -7 | -22.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MacroGenics | 293 |
| Adagene | 128 |
| Innate Pharma | 120 |
| Armata Pharmaceuticals | 61 |
| ALX Oncology Holdings | 48 |
| Protara Therapeutics | 46 |
| Zura Bio | 40 |
| Satellos Bioscience | 21 |
CMPX News
- 2 days ago - Compass Therapeutics Transcript: Stifel 2026 Healthcare Conference 2026 - Transcripts
- 4 days ago - Compass Therapeutics Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 4 days ago - Compass Therapeutics reports Q3 EPS (15c), consensus (13c) - TheFly
- 4 days ago - Compass Therapeutics Reports 2026 Third Quarter Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 days ago - Compass Therapeutics Quarterly report: Q3 2026 - Filings
- 4 days ago - Compass Therapeutics Earnings release: Q3 2026 - Filings
- 7 days ago - Compass Therapeutics Presents Novel Mechanism of Action Data for CTX-10726 (PD-1 x VEGF-A Bispecific Antibody) at the SITC 2026 Annual Meeting - GlobeNewsWire
- 11 days ago - Compass Therapeutics to Participate in Upcoming November Investor Events - GlobeNewsWire